Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis

Efficacy and safety of therapies for COVID-19 in pregnancy: a systematic review and meta-analysis

Abstract Background Clinical evidence suggests that pregnant women are more vulnerable to COVID-19, since they are at increased risk for disease progression and for obstetric complications, such as premature labor, miscarriage, preeclampsia, cesarean delivery, fetal growth restriction and perinatal...

Full description

Bibliographic Details
Main Authors: Francesco Di Gennaro, Giacomo Guido, Luisa Frallonardo, Francesco Vladimiro Segala, Rosalba De Nola, Gianluca Raffaello Damiani, Elda De Vita, Valentina Totaro, Mario Barbagallo, Emanuele Nicastri, Antonella Vimercati, Ettore Cicinelli, Giuseppina Liuzzi, Nicola Veronese, Annalisa Saracino
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
Pregnancy
SARS-CoV-2
Monoclonal antibodies
Antivirals
Maternal morbidity
Online Access:https://doi.org/10.1186/s12879-023-08747-2

Internet

https://doi.org/10.1186/s12879-023-08747-2

Similar Items